These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 18661775)

  • 1. Long-term follow-up of a girl with Maroteaux-Lamy syndrome after bone marrow transplantation.
    Wang CC; Hwu WL; Lin KH
    World J Pediatr; 2008 May; 4(2):152-4. PubMed ID: 18661775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow transplantation for Maroteaux-Lamy syndrome (MPS VI): long-term follow-up.
    Herskhovitz E; Young E; Rainer J; Hall CM; Lidchi V; Chong K; Vellodi A
    J Inherit Metab Dis; 1999 Feb; 22(1):50-62. PubMed ID: 10070618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone-marrow transplantation in the Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI). Biochemical and clinical status 24 months after transplantation.
    Krivit W; Pierpont ME; Ayaz K; Tsai M; Ramsay NK; Kersey JH; Weisdorf S; Sibley R; Snover D; McGovern MM
    N Engl J Med; 1984 Dec; 311(25):1606-11. PubMed ID: 6150438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI): a single dose of galsulfase further reduces urine glycosaminoglycans after hematopoietic stem cell transplantation.
    Whitley CB; Utz JR
    Mol Genet Metab; 2010 Dec; 101(4):346-8. PubMed ID: 20800524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Maroteaux-Lamy syndrome: a case report].
    Mtar A; Charfeddine B; Braham I; Ben Abdallah J; Neffati S; Smach MA; Bourfifa Z; Ksouri M; Dridi H; Limem K
    Ann Biol Clin (Paris); 2011; 69(6):693-7. PubMed ID: 22123570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of corneal graft survival following bone marrow transplantation in the Maroteaux-Lamy syndrome.
    Uçakhan OO; Brodie SE; Desnick R; Willner J; Asbell PA
    CLAO J; 2001 Oct; 27(4):234-7. PubMed ID: 11725989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Umbilical cord blood transplantation for Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI).
    Lee V; Li CK; Shing MM; Chik KW; Lam CW; Tsang KS; Pong H; Huen KF; Yuen PM
    Bone Marrow Transplant; 2000 Aug; 26(4):455-8. PubMed ID: 10982295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of clinical features and arylsulfatase B gene mutation in thirteen Chinese children with mucopolysaccharidosis type VI].
    Zheng J; Huang Y; Zhao X; Sheng H; Cheng J; Zhou Z; Li X; Mao X; Liu L
    Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):403-8. PubMed ID: 25190157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human N-acetylgalactosamine 4-sulfatase.
    Harmatz P; Ketteridge D; Giugliani R; Guffon N; Teles EL; Miranda MC; Yu ZF; Swiedler SJ; Hopwood JJ;
    Pediatrics; 2005 Jun; 115(6):e681-9. PubMed ID: 15930196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme replacement therapy improves joint motion and outcome of the 12-min walk test in a mucopolysaccharidosis type VI patient previously treated with bone marrow transplantation.
    Sohn YB; Park SW; Kim SH; Cho SY; Ji ST; Kwon EK; Han SJ; Oh SJ; Park YJ; Ko AR; Paik KH; Lee J; Lee DH; Jin DK
    Am J Med Genet A; 2012 May; 158A(5):1158-63. PubMed ID: 22495825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recommendations for the management of MPS VI: systematic evidence- and consensus-based guidance.
    Akyol MU; Alden TD; Amartino H; Ashworth J; Belani K; Berger KI; Borgo A; Braunlin E; Eto Y; Gold JI; Jester A; Jones SA; Karsli C; Mackenzie W; Marinho DR; McFadyen A; McGill J; Mitchell JJ; Muenzer J; Okuyama T; Orchard PJ; Stevens B; Thomas S; Walker R; Wynn R; Giugliani R; Harmatz P; Hendriksz C; Scarpa M; ;
    Orphanet J Rare Dis; 2019 May; 14(1):118. PubMed ID: 31142378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction of feline arylsulphatase B deficiency (mucopolysaccharidosis VI) by bone marrow transplantation.
    Gasper PW; Thrall MA; Wenger DA; Macy DW; Ham L; Dornsife RE; McBiles K; Quackenbush SL; Kesel ML; Gillette EL
    Nature; 1984 Nov 29-Dec 5; 312(5993):467-9. PubMed ID: 6438532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow transplantation in Maroteaux-Lamy syndrome (MPS type 6): status 40 months after BMT.
    McGovern MM; Ludman MD; Short MP; Steinfeld L; Kattan M; Raab EL; Krivit W; Desnick RJ
    Birth Defects Orig Artic Ser; 1986; 22(1):41-53. PubMed ID: 3083886
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of MPS VII (Sly disease) by allogeneic BMT in a female with homozygous A619V mutation.
    Yamada Y; Kato K; Sukegawa K; Tomatsu S; Fukuda S; Emura S; Kojima S; Matsuyama T; Sly WS; Kondo N; Orii T
    Bone Marrow Transplant; 1998 Mar; 21(6):629-34. PubMed ID: 9543069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An index case for the attenuated end of the mucopolysaccharidosis type VI clinical spectrum.
    Brooks DA; Gibson GJ; Karageorgos L; Hein LK; Robertson EF; Hopwood JJ
    Mol Genet Metab; 2005 Jul; 85(3):236-8. PubMed ID: 15979036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up to five years experience with 11 mucopolysaccharidosis type VI patients.
    Brands MM; Oussoren E; Ruijter GJ; Vollebregt AA; van den Hout HM; Joosten KF; Hop WC; Plug I; van der Ploeg AT
    Mol Genet Metab; 2013 May; 109(1):70-6. PubMed ID: 23523338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of arylsulfatase B gene mutations and clinical presentations of Iranian patients with Mucopolysaccharidosis VI.
    Aminzadeh M; Malekpour N; Ghandil P
    Gene; 2019 Jul; 706():1-5. PubMed ID: 31009684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: Final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase.
    Harmatz P; Giugliani R; D Schwartz IV; Guffon N; Teles EL; Miranda MCS; Wraith JE; Beck M; Arash L; Scarpa M; Ketteridge D; Hopwood JJ; Plecko B; Steiner R; Whitley CB; Kaplan P; Yu ZF; Swiedler SJ; Decker C;
    Mol Genet Metab; 2008 Aug; 94(4):469-475. PubMed ID: 18502162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syringomyelia in mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome): imaging findings following bone marrow transplantation.
    Hite SH; Krivit W; Haines SJ; Whitley CB
    Pediatr Radiol; 1997 Sep; 27(9):736-8. PubMed ID: 9285734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic CD34 selected peripheral stem cell transplant for Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI): rapid haemopoietic and biochemical reconstitution.
    Alvaro F; Toogood I; Fletcher JM; Clements P; Rawling T; To B
    Bone Marrow Transplant; 1998 Feb; 21(4):419-21. PubMed ID: 9509979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.